Medesign Pharmaceuticals Private Limited

Medesign Pharmaceuticals Private Limited - pharma in Delhi, India. FY 2026 financials & compliance.
CIN U74999DL2014PTC273841 Incorporated 06 December 2014 ROC Delhi HQ Delhi, India
Active Private Limited Company pharma MSME · Micro
Data last updated
Revenue · FY 2025
₹2.49 Lakh
▲ 6% YoY
Net loss · FY 2025
₹19.87 Lakh
Latest filing
EBITDA · FY 2025
-₹17.38 Lakh
Latest filing
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Company age
12 yrs
Est. 2014
Directors on board
2
As per MCA filings
Active GSTINs
1
of 2 registered

About Medesign Pharmaceuticals Private Limited

Data last updated:

Medesign Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 06 December 2014 and has been in existence for over 12 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74999DL2014PTC273841. Its GSTIN is 07AAJCM4966D1ZA (Delhi). The company holds 2 GST registrations, of which 1 is active.

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Pradeep Kumar Parashar and Rajnesh Giri.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at G – 10 Vivek Apartments Shreshtha Vihar Shahdara, Delhi, India – 110092.

As per the financials filed for FY 2025, the company reported a revenue of ₹2.49 Lakh, a growth of 6% compared to the previous year. For the same year it recorded a net loss of ₹19.87 Lakh and EBITDA of -₹17.38 Lakh. Revenue has declined at a compounded annual rate (CAGR) of 62% over three years and 57% over five years.

Court records list 6 cases involving the company, including 5 filed by the company and 1 filed against it.

Medesign Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-02-0017863). The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U74999DL2014PTC273841
Registration Number 273841
Incorporation Date 06 December 2014
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-DL-02-0017863
Key People
Pradeep Kumar Parashar Director Rajnesh Giri Director

Recognitions & Rankings of Medesign Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Micro (2024-25)
Udyam number
UDYAM-DL-02-0017863

Contact details

Medesign Pharmaceuticals Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    G – 10 Vivek Apartments Shreshtha Vihar Shahdara, Delhi, India – 110092
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Medesign Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Medesign Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Medesign Pharmaceuticals is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Medesign Pharmaceuticals Private Limited, buy the company report.

Financials of Medesign Pharmaceuticals Private Limited

FY 2024 filings available

Medesign Pharmaceuticals Private Limited reported revenue of ₹2.49 Lakh (up 6% YoY) for FY 2025.

Revenue · FY 2025
₹2.49 Lakh ▲ 6%
Net loss · FY 2025
₹19.87 Lakh
EBITDA · FY 2025
-₹17.38 Lakh

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 6%
3 years · compounded
▲ 62%
5 years · compounded
▼ 57%
EBITDA CAGR growth
1 year
▼ 189%
3 years · compounded
▼ 12%
5 years · compounded
▼ 51%

Revenue rose 6% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 57%. EBITDA fell 189% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹17.38 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹19.87 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin
Net Profit Margin
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Medesign Pharmaceuticals Private Limited, buy the company report.

Board of directors of Medesign Pharmaceuticals Private Limited

Medesign Pharmaceuticals has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Pradeep Kumar Parashar
Also directs: Lipika Telelinks Private Limited, Nephro Bioscience Private Limited, Tekisa Systems Private Limited and 3 more
Director20 Nov 20178 Years 11 MonthsCurrent
Rajnesh Giri
Also directs: Lipika Telelinks Private Limited, Eastcompeace India Private Limited, Thermo Cell Private Limited
Director16 Apr 20197 Years 6 MonthsCurrent
View all directors

Auditor

Medesign Pharmaceuticals Private Limited is audited by Kumar Mehra & Associates for the financial year 2023.

Auditor firmFinancial yearFirm registration number
Kumar Mehra & AssociatesFY 2023008740N

Shareholding

The shareholding of Medesign Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Medesign Pharmaceuticals Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Medesign Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Medesign Pharmaceuticals has 2 GST registrations: 1 active and 1 cancelled or inactive.

Total GSTINs
2
Active
1
Cancelled / inactive
1
GSTINStateStatusRegistered on
07AAJCM4966D1ZADelhiActive15 Dec 2017

To see the full GST registrations and return filing status of Medesign Pharmaceuticals Private Limited, buy the company report.

Recent activity

Medesign Pharmaceuticals Private Limited has 6 board changes on record since 2017: 2 appointments and 4 cessations. The latest: Rajnesh Giri ceased to be Additional Director on 30 Sep 2019.

AGM
Medesign Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Medesign Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
Ceased
Rajnesh Giri ceased to be Additional Director.
Ceased
Paras ceased to be Director.
Appointed
Rajnesh Giri was appointed as Director.
Ceased
Hina Raghunandan Giri ceased to be Director.
Appointed
Pradeep Kumar Parashar was appointed as Director.
Ceased
Baoxin Li ceased to be Director.
Incorporation
06 Dec 2014
Medesign Pharmaceuticals Private Limited was registered on 06 Dec 2014 with Roc Delhi & aged 11 years 10 months as per MCA records.

Frequently asked questions

Medesign Pharmaceuticals is an active private limited company based in Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 06 December 2014 (12+ years old) and is registered under CIN U74999DL2014PTC273841.

Medesign Pharmaceuticals has 2 current directors:

The latest financial statements of Medesign Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.

The GSTIN of Medesign Pharmaceuticals is 07AAJCM4966D1ZA, registered in Delhi. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.

The CIN (Corporate Identification Number) of Medesign Pharmaceuticals is U74999DL2014PTC273841. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Medesign Pharmaceuticals has 6 court cases on record: 5 filed by the company and 1 filed against it. Most are in the district courts.

Medesign Pharmaceuticals was incorporated on 06 December 2014, making it 12+ years old. It is registered with the Registrar of Companies, Delhi.

Rajnesh Giri ceased to be Additional Director on 30 Sep 2019. Paras ceased to be Director on 10 Jul 2019. Rajnesh Giri was appointed as Director on 16 Apr 2019. Medesign Pharmaceuticals has 6 board changes on record in total.

Yes, Medesign Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-02-0017863).

The registered office of Medesign Pharmaceuticals is at G – 10 Vivek Apartments Shreshtha Vihar Shahdara, Delhi, India – 110092.